| Short Description : | Recombinant-Human Erythropoietin/EPO-C-His protein was developed in hek293 cells using the region Ala28-Arg193. For use in research applications. |
| Host: | HEK293 cells |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Conjugation: | Unconjugated |
| Formulation: | Lyophilised from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
| Storage Instruction: | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Immunoreactivity: | 1.Measured by its binding ability in a functional ELISA. Immobilized Human EPO Protein at 5 Mu g/mL (100 Mu L/well) can bind EPOR with a linear range of 0.12-23.83 ng/mL.|2.Measured in a cell proliferation assay using TF-1 human erythroleukemic cells |
| Determination Method: | <0.1 EU/Mu g |
| Gene Symbol: | EPO |
| Gene ID: | 2056 |
| Uniprot ID: | EPO_HUMAN |
| Immunogen: | Recombinant Human Erythropoietin/EPO Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Ala28-Arg193) of human Erythropoietin/EPO (Accession #NP_000790.2) fused with a 6×His tag at the C-terminus. |
| Immunogen Region: | Ala28-Arg193 |
| Immunogen Sequence: | APPRLICDSRVLERYLLEAK EAENITTGCAEHCSLNENIT VPDTKVNFYAWKRMEVGQQA VEVWQGLALLSEAVLRGQAL LVNSSQPWEPLQLHVDKAVS GLRSLTTLLRALGAQKEAIS PPDAASAAPLRTITADTFRK LFRVYSNFLRGKLKLYTGEA CRTGDR |
Information sourced from Uniprot.org
